Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6093-6109
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6093
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6093
Table 4 Methylation and unmethylation status in the promoter region of p16, RASSF1A, and hMLH1within pancreatic cancer subjects
| Genes | Promoter methylation analysis status | Promoter unmethylation analysis status | P value for promoter methylation vs ummethylation |
| p16 | 21 | 29 | 0.05 |
| RASSF1A | 0 | 50 | 0.001 |
| hMLH1 | 4 | 46 | 0.165 |
- Citation: Rah B, Banday MA, Bhat GR, Shah OJ, Jeelani H, Kawoosa F, Yousuf T, Afroze D. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World J Gastroenterol 2021; 27(36): 6093-6109
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6093.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6093